ID   SHG-44/ADM
AC   CVCL_HF68
DR   Wikidata; Q54953323
RX   PubMed=25333456;
CC   Population: Chinese.
CC   Doubling time: 32.22 hours (PubMed=25333456).
CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Misspelling: SGH-44/ADM; PubMed=25333456; Note=In abstract and many parts of the text.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6728 ! SHG-44
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 12
//
RX   PubMed=25333456; DOI=10.3892/mmr.2014.2690; PMCID=PMC4237088;
RA   Chen J., Xu Z.-Y., Wang F.;
RT   "Association between DNA methylation and multidrug resistance in human
RT   glioma SHG-44 cells.";
RL   Mol. Med. Rep. 11:43-52(2015).
//